Goldman Sachs 45th Annual Global Healthcare Conference
Logotype for Elevance Health Inc

Elevance Health (ELV) Goldman Sachs 45th Annual Global Healthcare Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Elevance Health Inc

Goldman Sachs 45th Annual Global Healthcare Conference summary

3 Feb, 2026

Financial performance and utilization trends

  • Guidance reaffirmed with stable utilization trends across Medicare, Medicaid, and commercial lines, consistent with Q1 and expectations for Q2.

  • Medicare shows stabilization in inpatient trends, with some ongoing outpatient increases in cardio, physical therapy, and radiology.

  • Medicaid trends are driven by acuity mix shifts due to redeterminations, not by per-member utilization increases.

  • Commercial business trends remain stable and accurately priced, supporting continued confidence in outlook.

  • Ongoing active discussions with states on Medicaid rates, with constructive progress and actuarially sound rates expected.

Strategic initiatives and care delivery

  • Recent partnership with CD&R, Apree Health, and MPG aligns with a capital-efficient, enablement-focused approach to value-based care.

  • The strategy leverages strengths across commercial, Medicare, and Medicaid, with scalable, payer-agnostic solutions.

  • Synergies expected through technology integration, EMR capabilities, and specialty enablement, with a long-term plan to bring assets in-house.

  • Growth will be accelerated by targeted provider engagement and capital for acquisitions, with deliberate application of Carelon services.

  • Expansion into risk-based and global capitation arrangements in primary care, with subcapitated specialty partnerships for complex care.

Medicare and commercial business strategy

  • Medicare bids for 2025 were approached with discipline, focusing on margin stability and local market competitiveness.

  • Recent years saw exits from unprofitable plans and benefit rationalization, with margin improvement and stable to improving outlook for 2025.

  • Commercial margins have returned to pre-pandemic levels, with incremental opportunities for further improvement and growth in fee-based business.

  • Integrated pharmacy-medical solutions are increasingly demanded, especially in large group RFPs.

  • Down-market employers remain paternalistic, with limited appetite for ICHRAs, but ACA competitiveness supports membership retention.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more